- Europe, like you've never read before -
Friday, 20 November 2026
No Result
View All Result
  • en ENG
  • it ITA
Eunews
  • Politics
  • World
  • Business
  • News
  • Defence
  • Health
  • Agrifood
  • Other sections
    • Culture
    • Rights
    • Energy
    • Green Economy
    • Finance & Insurance
    • Industry & Markets
    • Media
    • Mobility & Logistics
    • Net & Tech
    • Sports
  • Eunews Newsletter
  • European 2024
    Eunews
    • Politics
    • World
    • Business
    • News
    • Defence
    • Health
    • Agrifood
    • Other sections
      • Culture
      • Rights
      • Energy
      • Green Economy
      • Finance & Insurance
      • Industry & Markets
      • Media
      • Mobility & Logistics
      • Net & Tech
      • Sports
    No Result
    View All Result
    Eunews
    No Result
    View All Result

    Home » General News » European Union lays groundwork for Alliance on critical medicines

    European Union lays groundwork for Alliance on critical medicines

    The future Alliance to Tackle Shortages of Drugs Considered Critical will run for 5 years and begin its work next spring, publishing initial recommendations on actions to improve supply by next fall

    Fabiana Luca</a> <a class="social twitter" href="https://twitter.com/@fabiana_luca" target="_blank">@fabiana_luca</a> by Fabiana Luca @fabiana_luca
    16 January 2024
    in General News

    Brussels – Brussels takes steps to make the European Health Union more concrete and, today (January 16), launched an open call to join a Critical Medicines Alliance to address potential drug shortages at the EU level.

    At the beginning of December, the EU executive drafted the first list of 200 active ingredients used for drugs for human use considered “critical” for the EU, prepared by the European Commission, the European Medicines Agency, and heads of Medicines Agencies of the Member States. The Alliance is the next step to ensure its community-wide supply.

    It will develop recommendations and advise the Commission, Member States, and other EU decision-makers on how to address long-standing drug shortages. The Alliance’s work will focus on drugs with the highest risk of shortages and the greatest impact on health systems and patients (based on a list the Commission will compile each year).

    Sources in the Italian industry of the sector say that ‘the idea is right, we will follow with great attention this attempt to respond to the critical issues that have arisen in particular since the Covid outbreak’. But the hope is that this activity launched by the Union’s executive will not stop at ‘widely consumed’ drugs, such as paracetamol, just to make us understand, ‘but that it will also deal holistically with new technologies and the new diseases that are unfortunately emerging’. In short, according to Italian industry, ‘it is necessary for this project to also look to the future and the innovative products that will be needed’.

    The future Alliance will have a 5-year duration and begin its work next spring, publishing initial recommendations on actions to be taken to improve the supply of essential medicines by the fall. Companies and organizations will be able to take part, but it will be also open to member states, local and regional authorities and their agencies, social partners, civil society, health professionals, patients, consumers, and other interest groups, bodies, and agencies of the EU.

    The launch of the Alliance “marks the beginning of a concerted push to strengthen and modernize the production of essential medicines in the EU and diversify international supply chains,” said EU Health Commissioner Stella Kyriakides, calling it “a new industrial pillar of our strong European Health Union.”

    Revision of EU standards

    In April, Brussels updated the pharmaceutical strategy with the first major overhaul in more than 20 years (the last legislation was in 2004) with a new legislative framework that focuses on access to medicines at low prices, innovation, and sustainability of the pharmaceutical industry, but also on a crisis-proof regulatory framework and initiatives against drug shortages and antimicrobial resistance. The European Commission wanted to strengthen obligations for companies to report drug shortages and withdrawals in advance and the development and maintenance of shortage prevention plans to fight the risk of drug shortages.

    European Health Commissioner Stella Kyriakides, 

    As part of this new pharma legislation, the Commission announced in recent months that it will work to draw up a list of medicines to be considered “critical” at the European level as part of the joint task force on the availability of medicines authorized for human and veterinary use, specifying further that the purpose of the list is to help ensure that the most critical medicines for health systems in the Union are always available.

    At the end of October, it adopted a communication dedicated to drug shortages, announcing a series of actions to better prevent and mitigate potential drug shortages in the EU by promoting the use of a voluntary European solidarity mechanism for medicines to deal with possible supply crises.

    English version by the Translation Service of Withub
    Tags: health unionpharmaci

    Related Posts

    Farmaci
    Health

    Every euro invested in innovative medicines yields 5.67 euros, EFPIA finds

    23 June 2026
    PHARMANUTRA AZIENDA INDUSTRIA FARMACEUTICA FARMACOLOGICA PRODUZIONE FARMACO FARMACI PILLOLA PILLOLE
    Health

    Critical medicines: green light for agreement between Parliament and Council – the EU aims for pharmaceutical sovereignty

    12 May 2026
    Farmaci
    Health

    New EU rules on medicines: more incentives for innovation and availability monitoring

    18 March 2026
    GUERRA COMMERCIALE DAZI TARIFFE SCONTRO STATI UNITI EUROPA BANDIERE SPESA GUANTONI BOX GENERATE AI IA
    World politics

    Trump now announces 100 percent tariffs on pharmaceuticals; EU projects confidence: ‘For us, they stay at 15 percent’

    26 September 2025
    CONTENT GROUP INDUSTRIA FARMACEUTICA LABORATORIO PRODUZIONE FARMACI COSMETICI DISPOSITIVI MEDICI GRUPPO FARMACEUTICO
    Health

    Court of Auditors: “Barriers to free movement still exist for drugs and medicines”

    17 September 2025
    [foto: Wikimedia Commons]
    Health

    EU authorizes first drug against Alzheimer’s

    16 April 2025
    map visualization
    Il primo ministro della Gran Bretagna, Andy Burnham, il presidente del Consiglio europeo, Antònio Costa, la presidente della Commissione europea, Ursula von der Leyen, prendono un tè informale al Summit UE-Regno Unito. Crediti: Consiglio dell'Unione europea

    Burnham declares Brexit a failure: “We want a better deal”

    by Iolanda Cuomo
    20 November 2026

    The British Prime Minister is in the Belgian capital for the second EU-UK Summit: “Today’s agreements cover the cost of...

    [Foto: Jérémie Mazenq. Copyright:
European Union , 2024

    Multiannual budget: EU Council reaches agreement in principle on a “stronger” civil protection mechanism

    by Emanuele Bonini emanuelebonini
    20 November 2026

    Member States have agreed on a more efficient emergency and crisis management mechanism. The outcome of the negotiations on the...

    Crediti foto: Sasun Bughdaryan via Unsplash

    EU sees record number of breast cancer prevention and treatment surgeries in 2024

    by Iolanda Cuomo
    20 November 2026

    Brussels – In 2024, there were 560,730 surgeries in the European Union to remove part of a mammary gland (partial excision) or...

    Sessione plenaria del Parlamento europeo a Strasburgo di luglio 2026. Crediti: Parlamento europeo

    EU budget, COP31, the cost-of-living crisis and – at last – a debate on Gaza: the European Parliament’s plenary agenda

    by Annachiara Magenta annacmag
    20 November 2026

    The next multiannual financial framework will dominate the debate among political groups. On Wednesday morning, MEPs will discuss the new...

    • Director’s Point of View
    • Opinions
    • About us
    • Contacts
    • Privacy Policy
    • Cookie policy

    Eunews is a registered newspaper
    Press Register of the Court of Turin n° 27

    Copyright © 2025 - WITHUB S.p.a., Via Savona 127/B, 20144 Milano
    VAT number: 10067080969 - ROC registration number n.30628
    Fully paid-up share capital 50.000,00€

     

    No Result
    View All Result
    • en ENG
    • it ITA
    • Politics
    • Newsletter
    • World politics
    • Business
    • General News
    • Defence & Security
    • Health
    • Agrifood
    • Altre sezioni
      • Culture
      • Rights
      • Energy
      • Green Economy
      • Gallery
      • Finance & Insurance
      • Industry & Markets
      • Media
      • Mobility & Logistics
      • Net & Tech
      • News
      • Opinions
      • Sports
    • Director’s Point of View
    • Draghi Report
    • Eunews Newsletter

    No Result
    View All Result
    • en ENG
    • it ITA
    • Politics
    • Newsletter
    • World politics
    • Business
    • General News
    • Defence & Security
    • Health
    • Agrifood
    • Altre sezioni
      • Culture
      • Rights
      • Energy
      • Green Economy
      • Gallery
      • Finance & Insurance
      • Industry & Markets
      • Media
      • Mobility & Logistics
      • Net & Tech
      • News
      • Opinions
      • Sports
    • Director’s Point of View
    • Draghi Report
    • Eunews Newsletter

    Attention